I agree, clarity on what they are doing is needed.
However it needs to be understood, LDX isn't a one trick pony.
They are primarily in the manufacturing game - they make tests for other people.
Having distribution rights means they they obtain fees for service from what they distribute through their own channels.
The TLIIQ system I am talking about could not be a one test platform as it could conduct a multitude of different tests from the one device.
The lateral flow assays contain the blood/samples and are then places in the reader to determine the disease/infection etc.
You could have a single platform whether LDX branded or other, conduct 50 tests on the one platform.
It doesnt matter how or why, as long as LDX obtains revenue from the product.
The end goal would be to have as much LDX branded kit in market and obtain as much cash from this as possible. But you can leverage partnerships to establish the sales channels for your own products etc via distribution of others.
LDX Price at posting:
3.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)